A detailed history of Sarasin & Partners LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Sarasin & Partners LLP holds 348,691 shares of ZTS stock, worth $60.4 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
348,691
Previous 206,195 69.11%
Holding current value
$60.4 Million
Previous $40.7 Million 44.98%
% of portfolio
0.58%
Previous 0.45%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$165.67 - $199.94 $23.6 Million - $28.5 Million
142,496 Added 69.11%
348,691 $59 Million
Q4 2023

Jan 09, 2024

SELL
$151.44 - $200.09 $4,997 - $6,602
-33 Reduced 0.02%
206,195 $40.7 Million
Q3 2023

Oct 05, 2023

BUY
$167.14 - $192.77 $8.81 Million - $10.2 Million
52,691 Added 34.32%
206,228 $35.9 Million
Q2 2023

Jul 10, 2023

BUY
$160.94 - $186.23 $5.98 Million - $6.92 Million
37,167 Added 31.94%
153,537 $26.4 Million
Q1 2023

May 05, 2023

SELL
$145.48 - $175.02 $7.69 Million - $9.25 Million
-52,854 Reduced 31.23%
116,370 $19.4 Million
Q1 2023

Apr 27, 2023

BUY
$145.48 - $175.02 $6.63 Million - $7.97 Million
45,562 Added 36.84%
169,224 $28.2 Million
Q4 2022

Jan 30, 2023

SELL
$131.14 - $157.47 $148,843 - $178,728
-1,135 Reduced 0.91%
123,662 $18.1 Million
Q3 2022

Oct 18, 2022

BUY
$148.29 - $182.55 $741,450 - $912,750
5,000 Added 4.17%
124,797 $18.5 Million
Q2 2022

Jul 13, 2022

SELL
$155.97 - $200.09 $1.6 Million - $2.06 Million
-10,288 Reduced 7.91%
119,797 $20.6 Million
Q1 2022

Apr 11, 2022

SELL
$181.39 - $234.03 $12.3 Million - $15.9 Million
-67,855 Reduced 34.28%
130,085 $24.5 Million
Q2 2021

Jul 13, 2021

BUY
$155.9 - $187.99 $10 Million - $12.1 Million
64,154 Added 47.95%
197,940 $36.9 Million
Q1 2021

Apr 29, 2021

BUY
$144.0 - $169.39 $7.58 Million - $8.91 Million
52,611 Added 64.81%
133,786 $21.1 Million
Q3 2020

Nov 09, 2020

BUY
$137.1 - $165.37 $2.03 Million - $2.45 Million
14,839 Added 22.37%
81,175 $13.4 Million
Q1 2020

Apr 30, 2020

BUY
$92.66 - $144.94 $696,525 - $1.09 Million
7,517 Added 12.78%
66,336 $7.81 Million
Q3 2019

Nov 08, 2019

BUY
$112.57 - $128.43 $1.11 Million - $1.27 Million
9,873 Added 20.17%
58,819 $7.33 Million
Q2 2019

Jul 18, 2019

BUY
$97.98 - $114.28 $208,207 - $242,845
2,125 Added 4.54%
48,946 $5.56 Million
Q4 2018

Feb 12, 2019

SELL
$79.28 - $95.27 $459,269 - $551,899
-5,793 Reduced 11.01%
46,821 $4.01 Million
Q3 2018

Nov 09, 2018

BUY
$83.5 - $93.23 $4.39 Million - $4.91 Million
52,614 New
52,614 $4.82 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Sarasin & Partners LLP Portfolio

Follow Sarasin & Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.